Faculty and Staff

Background

Bennett Doughty grew up in Winthrop, Maine, and earned his Doctor of Pharmacy degree with honors from the University of Connecticut School of Pharmacy in 2016. Following graduation, Doughty completed two years of residency training at the VA Connecticut Healthcare System in West Haven, Conn., specializing in psychiatric pharmacy.

Doughty joined the Binghamton School of Pharmacy and Pharmaceutical Sciences in 2018 as a clinical assistant professor in the Department of Pharmacy Practice. He also serves as a clinical psychiatric pharmacy specialist at the Guthrie Robert Packer Hospital in Sayre, Pa., where he has created an integrated outpatient psychiatric clinic within primary care. Doughty is the program director of the Binghamton University Opioid Overdose Prevention Program (BU OOPP), a state-sponsored program that supports the training and distribution of the opioid overdose reversal agent, Narcan, to the University community. He is also the director of Binghamton University’s and SUNY Upstate Medical University’s Rural and Underserved Service Track (TRUST), a co-curricular track that aims to provide our students with unique, interprofessional experiences working with underserved populations throughout New York and Pennsylvania. Doughty is also a Community-Engaged Teaching Fellow, recognized by the Binghamton University Center for Civic Engagement.

Doughty’s research interests primarily focus on the engagement of patients in substance use disorder treatment but also have expanded to include focus on interprofessional care in underserved communities

Doughty is a Board-Certified Pharmacotherapy Specialist (BCPS) and a Board-Certified Psychiatric Pharmacist (BCPP).

Recent Publications

• Doughty, B., Young, S., Eggleston, W. Assessment of a comprehensive naloxone education program’s impact on community member knowledge and attitudes on a college campus. Journal of American College Health. 2020.
• Doughty, B., Tumey, L. N. and Williams, K. "Case report: Albendazole associated psychosis."Mental Health Clin. 2019.
• Doughty B, Morgenson D, Brooks T. "Lofexidine: A newly FDA -approved nonopioid treatment for opioid withdrawal."Ann Pharmacother. 2019:1060028019828954.

Education

• PharmD, University of Connecticut
• BS Pharmacy, University of Connecticut

Research Interests

• Patient engagement in substance abuse treatment
• Opioid harm reduction initiatives
• Interprofessional patient care

Awards

• Council/Foundation Award for Service to the University, Binghamton Council and the Binghamton Foundation, 2022
• Preceptor of the Year Award, Binghamton University School of Pharmacy and Pharmaceutical Sciences, 2022
• Teacher of the Year Award, Binghamton University School of Pharmacy and Pharmaceutical Sciences, 2021, 2022
• Individual Development Award, Binghamton University, 2019, 2020, 2022
• Lilly Scholastic and Professional Achievement Award, University of Connecticut, 2016
• Rho Chi Pharmacy Honor Society, University of Connecticut, 2016
• Urban Health Scholar, University of Connecticut, 2016

Research Profile

• Google Scholar